STOCK TITAN

MeiraGTx (MGTX) CEO sells 62K shares at $7.41 under 10b5-1 plan

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

MeiraGTx Holdings plc’s President and CEO Alexandria Forbes reported an open-market sale of 62,000 Ordinary Shares of MGTX. The shares were sold at a weighted average price of $7.41 per share in multiple transactions between $7.27 and $7.56.

The transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. Following these sales, Forbes directly holds 1,449,695 Ordinary Shares of MeiraGTx.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Forbes Alexandria

(Last)(First)(Middle)
655 THIRD AVENUE
SUITE 1115

(Street)
NEW YORK NEW YORK 10017

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MeiraGTx Holdings plc [ MGTX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
PRESIDENT & CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/24/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares03/24/2026S(1)62,000D$7.41(2)(3)1,449,695D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.
2. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $7.27 to $7.56, inclusive.
3. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
/s/ Richard Giroux, Attorney-in-Fact for Alexandria Forbes03/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MeiraGTx (MGTX) report for Alexandria Forbes?

MeiraGTx reported that President and CEO Alexandria Forbes sold 62,000 Ordinary Shares in an open-market transaction. The sale was disclosed on Form 4 and reflects a routine insider trade executed under a pre-arranged Rule 10b5-1 trading plan.

How many MeiraGTx (MGTX) shares did the CEO sell and at what price?

The CEO sold 62,000 Ordinary Shares of MeiraGTx at a weighted average price of $7.41 per share. According to the disclosure, individual trades occurred in a price range from $7.27 to $7.56 per share during the transaction.

How many MeiraGTx (MGTX) shares does the CEO hold after this Form 4 sale?

After the reported sale, Alexandria Forbes directly owns 1,449,695 Ordinary Shares of MeiraGTx. This remaining holding, shown in the Form 4 data, provides context for the size of the 62,000-share sale relative to her overall direct ownership stake.

Was the MeiraGTx (MGTX) CEO’s share sale made under a Rule 10b5-1 plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. Such plans are pre-arranged, helping separate routine diversification from discretionary, market-timed insider trades.

What price range did MeiraGTx (MGTX) shares trade at in the CEO’s sale?

The Form 4 notes that the CEO’s shares were sold in multiple transactions at prices ranging from $7.27 to $7.56, inclusive. The reported weighted average sales price was $7.41 per share across the 62,000 Ordinary Shares sold.

Can investors see the exact trade breakdown for the MeiraGTx (MGTX) CEO sale?

The filing explains that the CEO will provide full information on the number of shares sold at each separate price upon request. This commitment applies to the SEC staff, the issuer, or any security holder who asks for detailed trade data.
Meiragtx Holdings Plc

NASDAQ:MGTX

View MGTX Stock Overview

MGTX Rankings

MGTX Latest News

MGTX Latest SEC Filings

MGTX Stock Data

596.44M
53.38M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
NEW YORK